What's in TSH Biopharm Corporation Limited's pipeline?

TSH Biopharm Corporation Limited has 3 drugs in our index: 1 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with TSH Biopharm Corporation Limited's portfolio?

Top competitors by shared drug class: AstraZeneca, Centre for Chronic Disease Control, India, Federation Francophone de Cancerologie Digestive, Providence Health & Services, Shanghai Henlius Biotech.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/tsh-biopharm-corporation-limited.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

TSH Biopharm Corporation Limited — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

TSH Biopharm Corporation Limited pipeline: 1 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Amlodipine+Benazepril	Amlodipine+Benazepril	marketed	Calcium channel blocker + ACE inhibitor combination	L-type voltage-gated calcium channels; Angiotensin-converting enzyme (ACE)	Cardiovascular
RANCAD	RANCAD	phase 3	CTLA-4 inhibitor	CTLA-4	Oncology
Corever	Corever	phase 3			Other

Therapeutic area mix

Cardiovascular · 1
Oncology · 1
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AstraZeneca · 1 shared drug class
Centre for Chronic Disease Control, India · 1 shared drug class
Federation Francophone de Cancerologie Digestive · 1 shared drug class
Providence Health & Services · 1 shared drug class
Shanghai Henlius Biotech · 1 shared drug class
Takara Bio Inc. · 1 shared drug class
The Netherlands Cancer Institute · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for TSH Biopharm Corporation Limited:

Cite this brief

Drug Landscape (2026). TSH Biopharm Corporation Limited — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/tsh-biopharm-corporation-limited. Accessed 2026-05-17.